The cost-effectiveness of an inner-city asthma intervention for children Sean D. Sullivan, PhDa, Kevin B. Weiss, MD, MPHb, Henry Lynn, PhDc, Herman Mitchell, PhDc, Meyer Kattan, MDd, Peter J. Gergen, MD, MPHe, Richard Evans, MD, MPHf Journal of Allergy and Clinical Immunology Volume 110, Issue 4, Pages 576-581 (October 2002) DOI: 10.1067/mai.2002.128009 Copyright © 2002 Mosby, Inc. Terms and Conditions
Fig. 1 The acceptability curve shows the cumulative distribution of the ICER values in the bootstrap sample. It presents evidence in favor of the NCICAS intervention being cost-effective for different values of the maximum acceptable incremental cost per SFD appropriate for decision making. For example, the 50% point on the acceptability curve corresponds to the point estimate of cost-effectiveness and implies that there is a 50% chance of seeing an ICER of $9.20 per SFD gained with the NCICAS intervention. Journal of Allergy and Clinical Immunology 2002 110, 576-581DOI: (10.1067/mai.2002.128009) Copyright © 2002 Mosby, Inc. Terms and Conditions